Increase in Intracranial Pressure (ICP)

DBCOND0113421Nervous System DiseasesSigns, Symptoms, and General Pathologies

Increase in Intracranial Pressure (ICP) is the indication for 2 drugs in DrugBank. It is covered by 3 curated, structured indications.

Also known as
Intracranial pressure increased · Intracranial Hypertension · Increased Intracranial Pressure · Increased Intracraneal Pressure · Elevated Intracranial Pressure
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0029084SNOMED CT155052007MedDRA10011570UMLSC0151740

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
3Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
27Clinical trialsPhase, status and sponsor resolved per trial
Sign in
5Contraindicated drugsDrugs whose labels contraindicate them in this condition
Sign in
46Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Increase in Intracranial Pressure (ICP) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In